Guiying Hu

759 total citations
23 papers, 507 citations indexed

About

Guiying Hu is a scholar working on Epidemiology, Molecular Biology and Small Animals. According to data from OpenAlex, Guiying Hu has authored 23 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 5 papers in Small Animals. Recurrent topics in Guiying Hu's work include Cervical Cancer and HPV Research (7 papers), Cancer-related Molecular Pathways (4 papers) and Brucella: diagnosis, epidemiology, treatment (4 papers). Guiying Hu is often cited by papers focused on Cervical Cancer and HPV Research (7 papers), Cancer-related Molecular Pathways (4 papers) and Brucella: diagnosis, epidemiology, treatment (4 papers). Guiying Hu collaborates with scholars based in China, United States and Türkiye. Guiying Hu's co-authors include Wei Zhang, Albert Deisseroth, A. B. Deisseroth, Elihu H. Estey, W. Liu, J Hester, Wei Zhang, AB Deisseroth, Robert Radinsky and John Mendelsohn and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Gene.

In The Last Decade

Guiying Hu

21 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiying Hu China 13 200 196 194 92 77 23 507
Michael J. Murphy United States 14 140 0.7× 343 1.8× 243 1.3× 13 0.1× 57 0.7× 44 820
James C. Cooke United Kingdom 7 201 1.0× 185 0.9× 238 1.2× 8 0.1× 78 1.0× 7 571
Sarah Whelan United Kingdom 11 51 0.3× 288 1.5× 127 0.7× 7 0.1× 107 1.4× 25 681
Florian Anderl Germany 13 156 0.8× 237 1.2× 173 0.9× 43 0.5× 18 0.2× 15 770
Hilda Holcombe United States 11 62 0.3× 99 0.5× 162 0.8× 19 0.2× 35 0.5× 22 736
Aki Imai‐Matsushima Germany 8 93 0.5× 66 0.3× 143 0.7× 19 0.2× 41 0.5× 8 456
Axel Nogai Germany 10 35 0.2× 137 0.7× 205 1.1× 8 0.1× 36 0.5× 28 583
Susan A. Kraegel United States 12 40 0.2× 114 0.6× 100 0.5× 60 0.7× 28 0.4× 18 409
Catherine Ibisch France 10 95 0.5× 149 0.8× 65 0.3× 87 0.9× 21 0.3× 18 431
L de Leij Netherlands 13 164 0.8× 293 1.5× 274 1.4× 4 0.0× 21 0.3× 26 707

Countries citing papers authored by Guiying Hu

Since Specialization
Citations

This map shows the geographic impact of Guiying Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiying Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiying Hu more than expected).

Fields of papers citing papers by Guiying Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiying Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiying Hu. The network helps show where Guiying Hu may publish in the future.

Co-authorship network of co-authors of Guiying Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Guiying Hu. A scholar is included among the top collaborators of Guiying Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiying Hu. Guiying Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Keyu, Qinqin Yu, Guiying Hu, et al.. (2025). Design of amides and long-chain alkyl alcohols for high selectivity recovery of titanium and iron from ilmenite. Minerals Engineering. 233. 109647–109647.
3.
4.
Shen, Ling, Yuancheng Li, Guiying Hu, et al.. (2023). Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling. Functional & Integrative Genomics. 23(2). 133–133. 15 indexed citations
5.
Shen, Ling, et al.. (2020). <p>MIR155HG Knockdown Inhibited the Progression of Cervical Cancer by Binding SRSF1</p>. OncoTargets and Therapy. Volume 13. 12043–12054. 14 indexed citations
6.
Li, Meijuan, Tingyan Liu, Ganfeng Luo, et al.. (2020). Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007–2018: A retrospective cohort study. Journal of Infection and Public Health. 14(1). 42–49. 28 indexed citations
7.
Zhang, Shaokai, Xiping Luo, Zhifang Li, et al.. (2020). [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].. PubMed. 42(3). 252–256. 3 indexed citations
8.
Luo, Ganfeng, Xiaoli Sun, Meijuan Li, et al.. (2019). Cervical human papillomavirus among women in Guangdong, China 2008‐2017: Implication for screening and vaccination. Journal of Medical Virology. 91(10). 1856–1865. 27 indexed citations
9.
Zhou, Xiangcheng, Guiying Hu, Hua Deng, et al.. (2018). The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women. BMC Cancer. 18(1). 1182–1182. 28 indexed citations
10.
Ma, Junying, Hu Wang, Xuefei Zhang, et al.. (2016). MLVA and MLST typing of Brucella from Qinghai, China. Infectious Diseases of Poverty. 5(1). 26–26. 44 indexed citations
11.
Chen, Yongxiu, et al.. (2016). WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use. BioMed Research International. 2016. 1–7. 7 indexed citations
12.
Xu, Liqing, et al.. (2015). An application of geographic information system for brucellosis prevention and control in Sanjiangyuan Region, Qinghai Province. Chin J Endemiol. 34(5). 315–317. 1 indexed citations
13.
Xu, Liqing, et al.. (2013). Application of a geographic information system on spatial distribution of Brucella abortus species in Qinghai Province. Chin J Endemiol. 32(5). 486–488. 1 indexed citations
15.
Hu, Guiying, et al.. (2003). A novel mutation in the ARS (component B) gene encoding SLURP-1 in a family with Mal de Meleda. Clinical and Experimental Dermatology. 28(5). 542–544. 9 indexed citations
16.
Hu, Guiying, W. Liu, John Mendelsohn, et al.. (1997). Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. JNCI Journal of the National Cancer Institute. 89(17). 1271–1276. 64 indexed citations
17.
Hu, Guiying, et al.. (1995). Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.. PubMed. 2(1). 19–32. 33 indexed citations
18.
Hu, Guiying, Wei Zhang, & Albert Deisseroth. (1992). P53 gene mutations in acute myelogenous leukaemia. British Journal of Haematology. 81(4). 489–494. 51 indexed citations
19.
Zhang, Wei, Guiying Hu, & Albert Deisseroth. (1992). Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia. Gene. 117(2). 271–275. 29 indexed citations
20.
Zhang, Wei, Guiying Hu, Elihu H. Estey, J Hester, & A. B. Deisseroth. (1992). Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells.. PubMed. 7(8). 1645–7. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026